These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22573814)

  • 61. Receptor-Arrestin Interactions: The GPCR Perspective.
    Seyedabadi M; Gharghabi M; Gurevich EV; Gurevich VV
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33557162
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Arrestin interactions with G protein-coupled receptors.
    Lohse MJ; Hoffmann C
    Handb Exp Pharmacol; 2014; 219():15-56. PubMed ID: 24292823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of conformational ensembles in ligand recognition in G-protein coupled receptors.
    Niesen MJ; Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2011 Aug; 133(33):13197-204. PubMed ID: 21766860
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural insights into emergent signaling modes of G protein-coupled receptors.
    Sutkeviciute I; Vilardaga JP
    J Biol Chem; 2020 Aug; 295(33):11626-11642. PubMed ID: 32571882
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural features of activated GPCR signaling complexes.
    Wang J; Hua T; Liu ZJ
    Curr Opin Struct Biol; 2020 Aug; 63():82-89. PubMed ID: 32485565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A constitutively activating mutation alters the dynamics and energetics of a key conformational change in a ligand-free G protein-coupled receptor.
    Tsukamoto H; Farrens DL
    J Biol Chem; 2013 Sep; 288(39):28207-16. PubMed ID: 23940032
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Conformational selection and equilibrium governs the ability of retinals to bind opsin.
    Schafer CT; Farrens DL
    J Biol Chem; 2015 Feb; 290(7):4304-18. PubMed ID: 25451936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent developments in biased agonism.
    Wisler JW; Xiao K; Thomsen AR; Lefkowitz RJ
    Curr Opin Cell Biol; 2014 Apr; 27():18-24. PubMed ID: 24680426
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Constitutive activation and endocytosis of the complement factor 5a receptor: evidence for multiple activated conformations of a G protein-coupled receptor.
    Whistler JL; Gerber BO; Meng EC; Baranski TJ; von Zastrow M; Bourne HR
    Traffic; 2002 Dec; 3(12):866-77. PubMed ID: 12453150
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Translating in vitro ligand bias into in vivo efficacy.
    Luttrell LM; Maudsley S; Gesty-Palmer D
    Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phosphorylation motif dictates GPCR C-terminal domain conformation and arrestin interaction.
    Guillien M; Mouhand A; Sagar A; Fournet A; Allemand F; Pereira GAN; Thureau A; Bernadó P; Banères JL; Sibille N
    Structure; 2023 Nov; 31(11):1394-1406.e7. PubMed ID: 37669668
    [TBL] [Abstract][Full Text] [Related]  

  • 74. G protein-coupled receptors--recent advances.
    Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
    Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decay of an active GPCR: Conformational dynamics govern agonist rebinding and persistence of an active, yet empty, receptor state.
    Schafer CT; Fay JF; Janz JM; Farrens DL
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11961-11966. PubMed ID: 27702898
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure-function analysis of β-arrestin Kurtz reveals a critical role of receptor interactions in downregulation of GPCR signaling in vivo.
    Chai F; Xu W; Musoke T; Tarabelsi G; Assaad S; Freedman J; Peterson R; Piotrowska K; Byrnes J; Rogers S; Veraksa A
    Dev Biol; 2019 Nov; 455(2):409-419. PubMed ID: 31325455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency.
    Chidiac P
    Methods; 2016 Jan; 92():87-93. PubMed ID: 26297537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT
    Denzinger K; Nguyen TN; Noonan T; Wolber G; Bermudez M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Traceable Peptidic Ligands that Target Ghrelin Receptors.
    Liu M; Wade J; Hossain MA
    Curr Protein Pept Sci; 2020; 21(10):955-964. PubMed ID: 32614744
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exploring the Technology Landscape of 7TMR Drug Signaling Profiling.
    Mancini A; Frauli M; Breton B
    Curr Top Med Chem; 2015; 15(24):2528-42. PubMed ID: 26126903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.